Follow
Miranda D Grounds
Miranda D Grounds
Verified email at uwa.edu.au
Title
Cited by
Cited by
Year
Towards understanding skeletal muscle regeneration
MD Grounds
Pathology-Research and Practice 187 (1), 1-22, 1991
5231991
Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes
MD Grounds, KL Garrett, MC Lai, WE Wright, MW Beilharz
Cell and tissue research 267, 99-104, 1992
4101992
The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis
TA Robertson, MAL Maley, MD Grounds, JM Papadimitriou
Experimental cell research 207 (2), 321-331, 1993
3781993
Age‐associated Changes in the Response of Skeletal Muscle Cells to Exercise and Regenerationa
MD Grounds
Annals of the New York Academy of Sciences 854 (1), 78-91, 1998
3741998
New horizons in the pathogenesis, diagnosis and management of sarcopenia
AA Sayer, SM Robinson, HP Patel, T Shavlakadze, C Cooper, ...
Age and ageing 42 (2), 145-150, 2013
3642013
Rapid death of injected myoblasts in myoblast transfer therapy
Y Fan, M Maley, M Beilharz, M Grounds
Muscle & Nerve: Official Journal of the American Association of …, 1996
3601996
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy
MD Grounds, HG Radley, GS Lynch, K Nagaraju, A De Luca
Neurobiology of disease 31 (1), 1-19, 2008
3552008
Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability
PW Hamer, JM McGeachie, MJ Davies, MD Grounds
Journal of anatomy 200 (1), 69-79, 2002
3522002
The role of stem cells in skeletal and cardiac muscle repair
MD Grounds, JD White, N Rosenthal, MA Bogoyevitch
Journal of Histochemistry & Cytochemistry 50 (5), 589-610, 2002
3482002
Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis
MD Grounds, JO Torrisi
The FASEB Journal 18 (6), 676-682, 2004
3162004
Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice
S Hodgetts, H Radley, M Davies, MD Grounds
Neuromuscular Disorders 16 (9-10), 591-602, 2006
2932006
Molecular and cell biology of skeletal muscle regeneration
MD Grounds, Z Yablonka-Reuveni
Molecular and cell biology of muscular dystrophy, 210-256, 1993
2541993
Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling
MD Grounds
Biogerontology 3, 19-24, 2002
2372002
Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle
RJ Chai, J Vukovic, S Dunlop, MD Grounds, T Shavlakadze
PloS one 6 (12), e28090, 2011
2362011
Evidence of fusion between host and donor myoblasts in skeletal muscle grafts
TA Partridge, M Grounds, JC Sloper
Nature 273 (5660), 306-308, 1978
2311978
The role of tumor necrosis factor-alpha (TNF-α) in skeletal muscle regeneration: studies in TNF-α (-/-) and TNF-α (-/-)/LT-α (-/-) mice
RA Collins, MD Grounds
Journal of Histochemistry & Cytochemistry 49 (8), 989-1001, 2001
2272001
Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies
JR Terrill, HG Radley‐Crabb, T Iwasaki, FA Lemckert, PG Arthur, ...
The FEBS journal 280 (17), 4149-4164, 2013
1972013
Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies
JK McGeachie, MD Grounds, TA Partridge, JE Morgan
Journal of the neurological sciences 119 (2), 169-179, 1993
1911993
Strength at the extracellular matrix–muscle interface
MD Grounds, L Sorokin, J White
Scandinavian journal of medicine & science in sports 15 (6), 381-391, 2005
1852005
Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1. 1+ cells
SI Hodgetts, MW Beilharz, AA Scalzo, MD Grounds
Cell transplantation 9 (4), 489-502, 2000
1842000
The system can't perform the operation now. Try again later.
Articles 1–20